The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Introduction
Measurable residual disease (MRD) is a prognostic factor for acute myeloid leukemia (AML). A next‐generation sequencing (NGS) based MRD panel was developed and the results were validated.
Methods
The NGS sequencing data was collected from 1003 Chinese AML patients.
Results
The sequencing data from 586 newly diagnosed AML patients showed that NRAS mutation was most common (20.8%),...